What is Examedi?
Founded in 2021 and headquartered in Las Condes, Chile, Examedi operates as a specialized provider of at-home medical services. The company bridges the gap between traditional clinical diagnostics and modern consumer convenience, offering a seamless digital platform for patients to schedule and receive medical testing in their own homes. By integrating logistics with clinical excellence, Examedi has carved out a distinct market position, effectively addressing the growing demand for decentralized healthcare solutions. The firm's business model is built upon a foundation of operational efficiency and patient-centric care, which has allowed it to rapidly capture market share in a competitive landscape. As a key innovator in the Chilean health-tech ecosystem, Examedi continues to optimize its service delivery, focusing on scalability and the integration of advanced health data management systems to enhance the overall patient experience.
How much funding has Examedi raised?
Examedi has raised a total of $17M across 1 funding round:
Series A
$17M
Series A (2022): $17M with participation from General Catalyst
Key Investors in Examedi
General Catalyst
General Catalyst is a venture capital firm that partners with founders to build transformational businesses, providing both capital and operational expertise across various growth stages.
What's next for Examedi?
Looking ahead, the strategic deployment of this capital will likely focus on aggressive market expansion and the enhancement of the company's technological infrastructure. With the support of its institutional partners, Examedi is expected to prioritize the development of new service verticals and the optimization of its supply chain to maintain its competitive edge. The company's trajectory suggests a move toward regional consolidation, as it seeks to replicate its successful Chilean model in neighboring markets. By focusing on sustainable growth and operational excellence, Examedi is poised to remain a critical component of the evolving digital health landscape, potentially setting the stage for future funding rounds or strategic partnerships that will further solidify its market leadership.
See full Examedi company page
